I am a serial bioentrepreneur with >20 years of combined industry and academic experience, leading interdisciplinary teams combining Biotechnology, Applied Immunology, SW, Engineering, and Big Data in various medical applications including Therapeutics, Dx, Medical devices, and Digital Health. I co-founded MeMed Dx, served as its Chairman and CTO for over a decade, and led the inception, development, clinical validation, regulation, and manufacturing of the entire MeMed technology suite, including the MeMed BV™ technology, and the MeMed Key™ POC platform, from an idea on a napkin to development completion.I hold a B.A. in Biology (Summa Cum Laude), a B.Sc. in medicine (Magna Cum Laude), a Ph.D. in molecular immunology, and six years of training at the Technion School of Medicine. I co-authored over 100 granted and pending patents, authored >35 peer-reviewed publications, and received multiple research excellence awards, including the Gutwirth Excellence Award and Wolf Award for research students. In 2019, I was listed as one of the top 25 voices in Precision Medicine. I was among the inceptors of the AI-based health data company Navina.ai and serve as its Chief Strategy Officer. In 2020, I founded Canopy Immuno-Therapeutics and serve as its CEO. Canopy is a stealth-mode biotech company engaged in the development of a novel, potentially curative immunotherapeutic approach for autoimmunity and life-threatening allergies.